PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.\', \'Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.\', \'Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.\', \'Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Medical Sciences Building, Toronto, Ontario, Canada. Electronic address: dweaver@uhnres.utoronto.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0002-9629(20)30238-X10.1016/j.amjms.2020.05.044
?:doi
?:hasPublicationType
?:journal
  • The American journal of the medical sciences
is ?:pmid of
?:pmid
?:pmid
  • 32622469
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all